DK0974598T3 - Hidtil ukendte erythromcinderivater, fremgangsmådetil fremstillingheraf og anvendelse heraf som lægemidler - Google Patents

Hidtil ukendte erythromcinderivater, fremgangsmådetil fremstillingheraf og anvendelse heraf som lægemidler

Info

Publication number
DK0974598T3
DK0974598T3 DK99401706.9T DK99401706T DK0974598T3 DK 0974598 T3 DK0974598 T3 DK 0974598T3 DK 99401706 T DK99401706 T DK 99401706T DK 0974598 T3 DK0974598 T3 DK 0974598T3
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceuticals
erythromycin derivatives
hitherto unknown
erythromycin
Prior art date
Application number
DK99401706.9T
Other languages
Danish (da)
English (en)
Inventor
Giuseppe Gigliotti
Alexis Denis
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9808795A external-priority patent/FR2780977B1/fr
Priority claimed from FR9905245A external-priority patent/FR2792637B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0974598T3 publication Critical patent/DK0974598T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK99401706.9T 1998-07-09 1999-07-08 Hidtil ukendte erythromcinderivater, fremgangsmådetil fremstillingheraf og anvendelse heraf som lægemidler DK0974598T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9808795A FR2780977B1 (fr) 1998-07-09 1998-07-09 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR9905245A FR2792637B1 (fr) 1999-04-26 1999-04-26 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
DK0974598T3 true DK0974598T3 (da) 2011-12-19

Family

ID=26234434

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99401706.9T DK0974598T3 (da) 1998-07-09 1999-07-08 Hidtil ukendte erythromcinderivater, fremgangsmådetil fremstillingheraf og anvendelse heraf som lægemidler

Country Status (8)

Country Link
US (1) US6433151B1 (enExample)
EP (1) EP0974598B1 (enExample)
JP (1) JP4573925B2 (enExample)
AT (1) ATE521619T1 (enExample)
CY (1) CY1112087T1 (enExample)
DK (1) DK0974598T3 (enExample)
ES (1) ES2372156T3 (enExample)
PT (1) PT974598E (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2273964T3 (es) * 1998-12-10 2007-05-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
EP1794171A2 (en) * 2004-07-28 2007-06-13 Ranbaxy Laboratories, Ltd. Ketolide derivatives as antibacterial agents
EP1812455A2 (en) * 2004-09-27 2007-08-01 Ranbaxy Laboratories Limited Erythromycin a derivatives as antibacterial agents
US20090170790A1 (en) * 2004-10-25 2009-07-02 Biswajit Das Ketolide derivatives as antibacterial agents
MX2007007598A (es) * 2004-12-21 2007-07-25 Pfizer Prod Inc Macrolidos.
EP1957085A2 (en) * 2005-11-08 2008-08-20 Ranbaxy Laboratories, Ltd. Macrolides as anti-inflammatory agents
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US20090130225A1 (en) * 2005-11-23 2009-05-21 Anjan Chakrabarti Macrolides derivatives as antibacterial agents
EP1954294A2 (en) * 2005-11-23 2008-08-13 Ranbaxy Laboratories Limited Use of macrolide derivatives for treating acne
WO2008072034A1 (en) * 2006-12-12 2008-06-19 Zambon S.P.A. Macrolide compounds endowed with antiinflammatory activity
AU2019403048B2 (en) * 2018-12-17 2025-01-23 Lunella Biotech, Inc. Triple combination therapies for targeting mitochondria and killing cancer stem cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) * 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
KR19990067492A (ko) * 1995-11-08 1999-08-25 스티븐 에프. 웨인스톡 트리사이클릭 에리트로마이신 유도체
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
BR9711661A (pt) * 1996-09-04 1999-08-24 Abbott Lab Composto composi-Æo farmac-utica e processos para controlar uma infec-Æo bacteriana em um mam¡fero e para preparar um composto
JP2001518476A (ja) * 1997-09-30 2001-10-16 アボット・ラボラトリーズ 抗菌活性を有する３’−ｎ−修飾６−ｏ−置換エリスロマイシンケトライド誘導体

Also Published As

Publication number Publication date
EP0974598B1 (fr) 2011-08-24
EP0974598A3 (fr) 2003-12-17
PT974598E (pt) 2011-11-23
EP0974598A2 (fr) 2000-01-26
ES2372156T3 (es) 2012-01-16
CY1112087T1 (el) 2015-11-04
US6433151B1 (en) 2002-08-13
ATE521619T1 (de) 2011-09-15
JP4573925B2 (ja) 2010-11-04
JP2000026494A (ja) 2000-01-25

Similar Documents

Publication Publication Date Title
CY1112087T1 (el) Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
HUP9902576A1 (hu) Új eritromicinszármazékok, eljárás előállításukra és alkalmazásuk gyógyászati készítményekben
DK0596802T3 (da) Erythromycinderivater, deres fremstilling og deres anvendelse som lægemidler
FR2518088B1 (fr) Nouveaux derives d'aminoacides, et leur application therapeutique
NO982606L (no) Naftylsubstituerte benzimidazolderivater som antikoagulanter
ATE226201T1 (de) Substituierte pyridylpyrazole
NO970175L (no) Pyrido-annellerte tienyl- og furanyl-oksazolidinoner
SE8502017D0 (sv) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
DE69813605D1 (de) Benzofuranderivate
TR200000586T2 (tr) Farmasötik maddelerin oral yoldan biyolojik kullanışlılığının arttırılması için bir yöntem, bileşimler ve kitler.
DK1026170T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO20001198L (no) Pyrrolopyrrolondervater som inhibitorer av nøytrofil elastase
BRPI0210746B8 (pt) derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação
IT1140209B (it) Reagenti per immunoluorescenza e metodo per la loro preparazione
TR199901386T2 (en) �midazopiridazinler.
ES531063A0 (es) Procedimiento para la preparacion de un nuevo compuesto heterociclico
AU553927B2 (en) Oxazolo- thiazolo- imidazolo (5,4-b) pyridines
NO994104L (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
NO985685D0 (no) Dibenzo-oksazepin- og -dioksazepin-derivater og deres anvendelse som anti-tumormidler
PT78410B (fr) Procede de preparation de polymethylene imines disubstituees
ATE126799T1 (de) Derivate von methylpiperazinoazepin, verfahren zu ihrer herstellung und verwendung.
FR2555576B1 (fr) Derives de n-(methoxyphenacyl)-amine, utilisation notamment en therapeutique et procede de preparation
FI902764A7 (fi) N-(3-(((aryyli)amino)sulfonyyli)-1H-1,2,4,-triatsol-5-yyli)amiinien valmistus
NO20010332D0 (no) Nye 6-deoksyerytromycinderivater, metoder for fremstilling av disse, og anvendelse som medisiner
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung